BARR, Kenneth Jay,MACLEAN, John,ZHANG, Hongjun,BERESIS, Richard Thomas,ANTHONY, Neville,DANIELS, Matthew H,LAPOINTE, Blair,SCIAMMETTA, Nunzio
申请号：
DK13829341
公开号：
DK2920149T3
申请日:
2013.08.14
申请国别(地区):
DK
年份:
2019
代理人:
摘要：
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
